Pfizer’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration on Monday for use in children aged 12 to 15.
Pfizer’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration on Monday for use in children aged 12 to 15.
